Veterinary Pain Management Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast 2024-2028
| Published: Feb 2024 | Pages: 159 | SKU: IRTNTR40044 |
Veterinary Pain Management Market 2024-2028
The global veterinary pain management market size is estimated to grow by USD 800.12 million, at a CAGR of 6.99% between 2023 and 2028.
Advances in veterinary medicine are a key driver in the market, enabling the development of innovative technologies to handle animal pain effectively. Ongoing research and technology advancements have resulted in the development of new medications, therapeutic approaches, and surgical techniques, broadening the range of pain management alternatives. For instance, the introduction of NSAIDs with enhanced efficacy and safety profiles demonstrates the way scientific advances improve pain management in animals. Furthermore, the emergence of specialized pain relief therapies such as nerve blocks and epidurals demonstrates the ongoing evolution of veterinary pain management approaches, resulting in more precise and tailored solutions for diverse species. Hence, owing to the ongoing advancements in veterinary medicine, the market is expected to witness significant growth during the forecast period.
What will be the Size of the Market During the Forecast Period?
To learn more about this report, Download Report Sample
Segmentation by Product, Distribution Channel and Geography Analysis
Product Analysis
Drugs
The market share growth by the drugs segment will be significant during the forecast period.The drugs segment, which is an essential product category in the market, is growing at a significant pace. This increase is due to increased awareness of pet well-being and the rising prevalence of many illnesses that cause discomfort in animals. This section includes pharmaceuticals such as nonsteroidal anti-inflammatory medicines (NSAIDs), opioids, and analgesics, which provide effective pain relief to companion animals and cattle.
Get a glance at the market contribution of various segments Download PDF Sample
The drugs segment was the largest and was valued at USD 1,055.38 million in 2018. Examples include carprofen, a popular non-steroidal anti-inflammatory drug (NSAIDs) for dogs, and meloxicam, which has anti-inflammatory and analgesic qualities. The increased demand for specialized medications that cater to various animal species, together with ongoing research and development in veterinary pharmacology, is likely to drive the growth of the drugs segment, which, in turn, is expected to drive the growth of the market during the forecast period.
Distribution Channel Analysis
Veterinary hospitals
Veterinary hospitals are growing as the primary distribution channel in the market, indicating a trend toward specialized care and comprehensive treatment options for animals. These hospitals are outfitted with advanced diagnostics and treatment facilities and serve as distribution hubs for products. Major pharmaceutical companies, including Zoetis Inc. and Elanco Animal Health Inc., work with veterinary hospitals around the world to ensure that their pain treatment products are widely available. Veterinary hospitals are preferred by pet owners looking for professional advice and access to a wide choice of pain treatment medicines, including analgesics and anti-inflammatory medications. This trend is expected to continue as pet healthcare becomes more sophisticated and owners prioritize their animals well-being and comfort, creating a favorable environment for the expansion of veterinary hospitals as significant, in turn, is expected to drive the growth of the market during the forecast period.
Pet care clinics
Pet care clinics are becoming an important distribution channel in the market, demonstrating a growing trend towards specialized treatment and in-house dispensing of veterinary pharmaceuticals. With an increased emphasis on preventive and specialized veterinary care, pet care clinics are actively stocking a variety of pain treatment medications, which is helping to drive the growth of the market. The ease of acquiring prescription medications and professional assistance at these clinics promotes the expansion of the global veterinary pain treatment market, which aligns with the global landscape of comprehensive pet healthcare services. Owing to such factors, pet care clinics are expected to gain significant traction as a distribution channel for product distribution. This will lead to the overall growth of the pet care clinics segments as a distribution channel, which, in turn, will drive the growth of the market during the forecast period.
Regional Analysis
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. The market in North America is growing rapidly due to a variety of factors. For instance, the regions increased pet ownership, along with increased awareness of animal welfare, has resulted in a surge in demand for effective pain management solutions. The substantial presence of leading market companies in North America, including Zoetis Inc., Elanco Animal Health Inc., and Boehringer Ingelheim International GmbH contributes to the vitality of the regional market. These companies are always introducing new and improved pain treatment products, utilizing their R&D expertise. The region's legislative structure emphasizes the relevance of supporting the use of novel approaches.
For instance, pet ownership in the region is regulated by organizations such as the American Veterinary Medical Association and others. North American veterinary hospitals and clinics are increasingly embracing multimodal approaches, which combine medications, physical therapy, and complementary therapies to treat pain holistically. As the demand for quality pet care grows, the market in North America is expected to maintain its position as a major contributor to the expansion of the regional market during the forecast period.
Buy Full Report Now
Key Market Players
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 14 market companies, including:
Assisi Animal Health - The company offers veterinary pain management through Targeted Pulsed Electromagnetic Field (tPEMF) technology that delivers a signal that is specifically tuned to either reduce inflammation and accelerate healing or reduce canine separation anxiety.
- Bimeda Holdings Ltd.
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Chanelle Pharma Group
- Dechra Pharmaceuticals Plc
- Durvet Animal Health Products
- Elanco Animal Health Inc.
- Manna Pro Products LLC
- Multi Radiance Medical,
- Norbrook Laboratories Ltd.
- Vetoquinol SA
- Virbac Group
- Zoetis Inc.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Key Drivers, Trends, Challenges, and Customer Landscape
There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, market trends and analysis, and challenges.
Key Drivers
The rising adoption due to increasing pet ownership is notably driving the market growth. Changing lifestyles and increased concern for the health and well-being of companion animals are key reasons driving demand for sophisticated veterinary pain treatment solutions. The number of pet-owning families in the US was approximately 70% or about 90.5 million families in 2021-22, indicating a significant growth in pet ownership.
Moreover, this increased pet ownership highlights a growing demand for products and services, as pet owners prioritize their animal's health and comfort, leading to drive the market growth and trends during the forecast period.
Significant Trends
Rising interest in nutraceuticals and alternative therapies is an emerging trend shaping the market growth. Pet owners are increasingly looking for alternatives to traditional drugs, creating a demand for acupuncture, herbal therapies, and nutraceuticals. For instance, herbal supplements such as anti-inflammatory qualities and omega-3 fatty acids promote joint health. Hence, they have grown in favour of treating pain in pets. Acupuncture, which is known for its ability to relieve pain and promote overall well-being, is being introduced into veterinary operations.
However, this tendency is consistent with the larger social change towards natural and holistic treatment for both humans and animals, emphasizing preventive and integrative approaches to veterinary care. Hence, owing to the rising interest in nutraceuticals and alternative therapies, the market is expected to witness growth during the forecast period.
Major Challenges
Issues with implementation due to a shortage of skilled veterinary professionals are a significant challenge hindering market growth. The difficulty of a competent veterinary professional scarcity poses a substantial barrier to the worldwide industry, particularly in places with high demand for veterinary services but a limited workforce. In such cases, the proper adoption of modern pain managing approaches may be jeopardized due to a lack of expertise and qualified specialists.
Additionally, the need for specialized training programs and initiatives to address this deficit is critical to the effective integration of modern pain management approaches into veterinary clinics around the world. Hence, a shortage of skilled veterinary professionals may limit the implementation of advanced pain control solutions, which may affect the growth affecting the growth of the market during the forecast period.
Key Market Customer Landscape
The market forecasting report includes the adoption lifecycle of the market research and growth, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market analysis and report also include key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.
Customer Landscape
Market Analyst Overview
Chemical processes within the body involve intricate interactions between various stimulus and the brain interpretation, leading to specific reactions. These stimuli can range from physical factors like temperature to chemical influences. In cases of inflammatory damage to tissues, veterinary practices often employ analgesic drugs to alleviate discomfort, especially in companion animals. Factors such as income levels in developed economies influence consumption patterns, including the intake of meat and milk, while also impacting animal health expenditure. As a result, pet insurance has become increasingly relevant to manage rising pet care costs, with veterinary practitioners playing a crucial role in ensuring the well-being of animals of varying types
Segment Overview
The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028.
- Product Outlook
- Drugs
- Devices
- Distribution Channel Outlook
- Veterinary hospitals
- Pet care clinics
- Pharmacy stores
- Region Outlook
- North America
- The U.S.
- Canada
- Europe
- The U.K.
- Germany
- France
- Rest of Europe
- Asia
- China
- India
- Rest of World (ROW)
- Brazil
- Argentina
- Australia
- North America
|
Veterinary Pain Management Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
159 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 6.99% |
|
Market Growth 2024-2028 |
USD 800.12 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
6.3 |
|
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
|
Performing market contribution |
North America at 37% |
|
Key countries |
US, Germany, UK, China, and Japan |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
|
Key companies profiled |
Assisi Animal Health, Bimeda Holdings Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Chanelle Pharma Group, Dechra Pharmaceuticals Plc, Durvet Animal Health Products, Elanco Animal Health Inc., Manna Pro Products LLC, Multi Radiance Medical, Norbrook Laboratories Ltd., Vetoquinol SA, Virbac Group, and Zoetis Inc. |
|
Market dynamics |
Parent market growth analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
What are the Key Data Covered in this Market Research Report?
- CAGR of the market during the forecast period
- Detailed information on factors that will drive the growth of the between 2024 and 2028
- Precise estimation of the size and its contribution of the market in focus to the parent market
- Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria
- Companies landscape comparing criticality of inputs and factors of differentiation
- Exclusive Matrix on companies position and classification
- Accurate predictions about upcoming trends and changes in consumer behavior
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the growth of companies
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2023
- 3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global veterinary pain management market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global veterinary pain management market 2018 - 2022 ($ million)
- 4.2 Product Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Product Segment 2018 - 2022 ($ million)
- 4.3 Distribution channel Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Distribution channel Segment 2018 - 2022 ($ million)
- 4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
- 4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
- 6.1 Market segments
- Exhibit 30: Chart on Product - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
- 6.2 Comparison by Product
- Exhibit 32: Chart on Comparison by Product
- Exhibit 33: Data Table on Comparison by Product
- 6.3 Drugs - Market size and forecast 2023-2028
- Exhibit 34: Chart on Drugs - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Drugs - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Drugs - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Drugs - Year-over-year growth 2023-2028 (%)
- 6.4 Devices - Market size and forecast 2023-2028
- Exhibit 38: Chart on Devices - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Devices - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Devices - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Devices - Year-over-year growth 2023-2028 (%)
- 6.5 Market opportunity by Product
- Exhibit 42: Market opportunity by Product ($ million)
- Exhibit 43: Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Distribution Channel
- 7.1 Market segments
- Exhibit 44: Chart on Distribution Channel - Market share 2023-2028 (%)
- Exhibit 45: Data Table on Distribution Channel - Market share 2023-2028 (%)
- 7.2 Comparison by Distribution Channel
- Exhibit 46: Chart on Comparison by Distribution Channel
- Exhibit 47: Data Table on Comparison by Distribution Channel
- 7.3 Veterinary hospitals - Market size and forecast 2023-2028
- Exhibit 48: Chart on Veterinary hospitals - Market size and forecast 2023-2028 ($ million)
- Exhibit 49: Data Table on Veterinary hospitals - Market size and forecast 2023-2028 ($ million)
- Exhibit 50: Chart on Veterinary hospitals - Year-over-year growth 2023-2028 (%)
- Exhibit 51: Data Table on Veterinary hospitals - Year-over-year growth 2023-2028 (%)
- 7.4 Pet care clinics - Market size and forecast 2023-2028
- Exhibit 52: Chart on Pet care clinics - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on Pet care clinics - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on Pet care clinics - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Pet care clinics - Year-over-year growth 2023-2028 (%)
- 7.5 Pharmacy stores - Market size and forecast 2023-2028
- Exhibit 56: Chart on Pharmacy stores - Market size and forecast 2023-2028 ($ million)
- Exhibit 57: Data Table on Pharmacy stores - Market size and forecast 2023-2028 ($ million)
- Exhibit 58: Chart on Pharmacy stores - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Pharmacy stores - Year-over-year growth 2023-2028 (%)
- 7.6 Market opportunity by Distribution Channel
- Exhibit 60: Market opportunity by Distribution Channel ($ million)
- Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 63: Chart on Market share by geography 2023-2028 (%)
- Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
- 9.2 Geographic comparison
- Exhibit 65: Chart on Geographic comparison
- Exhibit 66: Data Table on Geographic comparison
- 9.3 North America - Market size and forecast 2023-2028
- Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
- 9.4 Europe - Market size and forecast 2023-2028
- Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 9.5 Asia - Market size and forecast 2023-2028
- Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 9.7 US - Market size and forecast 2023-2028
- Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
- 9.8 Germany - Market size and forecast 2023-2028
- Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 9.9 China - Market size and forecast 2023-2028
- Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
- 9.10 UK - Market size and forecast 2023-2028
- Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
- 9.11 Japan - Market size and forecast 2023-2028
- Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 9.12 Market opportunity by geography
- Exhibit 103: Market opportunity by geography ($ million)
- Exhibit 104: Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 105: Impact of drivers and challenges in 2023 and 2028
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 107: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 108: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 109: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 110: Matrix on vendor position and classification
- 12.3 Assisi Animal Health
- Exhibit 111: Assisi Animal Health - Overview
- Exhibit 112: Assisi Animal Health - Product / Service
- Exhibit 113: Assisi Animal Health - Key offerings
- 12.4 Bimeda Holdings Ltd.
- Exhibit 114: Bimeda Holdings Ltd. - Overview
- Exhibit 115: Bimeda Holdings Ltd. - Product / Service
- Exhibit 116: Bimeda Holdings Ltd. - Key offerings
- 12.5 Boehringer Ingelheim International GmbH
- Exhibit 117: Boehringer Ingelheim International GmbH - Overview
- Exhibit 118: Boehringer Ingelheim International GmbH - Business segments
- Exhibit 119: Boehringer Ingelheim International GmbH - Key news
- Exhibit 120: Boehringer Ingelheim International GmbH - Key offerings
- Exhibit 121: Boehringer Ingelheim International GmbH - Segment focus
- 12.6 Ceva Sante Animale
- Exhibit 122: Ceva Sante Animale - Overview
- Exhibit 123: Ceva Sante Animale - Product / Service
- Exhibit 124: Ceva Sante Animale - Key offerings
- 12.7 Chanelle Pharma Group
- Exhibit 125: Chanelle Pharma Group - Overview
- Exhibit 126: Chanelle Pharma Group - Product / Service
- Exhibit 127: Chanelle Pharma Group - Key offerings
- 12.8 Dechra Pharmaceuticals Plc
- Exhibit 128: Dechra Pharmaceuticals Plc - Overview
- Exhibit 129: Dechra Pharmaceuticals Plc - Business segments
- Exhibit 130: Dechra Pharmaceuticals Plc - Key offerings
- Exhibit 131: Dechra Pharmaceuticals Plc - Segment focus
- 12.9 Durvet Animal Health Products
- Exhibit 132: Durvet Animal Health Products - Overview
- Exhibit 133: Durvet Animal Health Products - Product / Service
- Exhibit 134: Durvet Animal Health Products - Key offerings
- 12.10 Elanco Animal Health Inc.
- Exhibit 135: Elanco Animal Health Inc. - Overview
- Exhibit 136: Elanco Animal Health Inc. - Product / Service
- Exhibit 137: Elanco Animal Health Inc. - Key offerings
- 12.11 Manna Pro Products LLC
- Exhibit 138: Manna Pro Products LLC - Overview
- Exhibit 139: Manna Pro Products LLC - Product / Service
- Exhibit 140: Manna Pro Products LLC - Key offerings
- 12.12 Multi Radiance Medical
- Exhibit 141: Multi Radiance Medical - Overview
- Exhibit 142: Multi Radiance Medical - Product / Service
- Exhibit 143: Multi Radiance Medical - Key offerings
- 12.13 Norbrook Laboratories Ltd.
- Exhibit 144: Norbrook Laboratories Ltd. - Overview
- Exhibit 145: Norbrook Laboratories Ltd. - Product / Service
- Exhibit 146: Norbrook Laboratories Ltd. - Key offerings
- 12.14 Vetoquinol SA
- Exhibit 147: Vetoquinol SA - Overview
- Exhibit 148: Vetoquinol SA - Business segments
- Exhibit 149: Vetoquinol SA - Key news
- Exhibit 150: Vetoquinol SA - Key offerings
- Exhibit 151: Vetoquinol SA - Segment focus
- 12.15 Virbac Group
- Exhibit 152: Virbac Group - Overview
- Exhibit 153: Virbac Group - Business segments
- Exhibit 154: Virbac Group - Key news
- Exhibit 155: Virbac Group - Key offerings
- Exhibit 156: Virbac Group - Segment focus
- 12.16 Zoetis Inc.
- Exhibit 157: Zoetis Inc. - Overview
- Exhibit 158: Zoetis Inc. - Business segments
- Exhibit 159: Zoetis Inc. - Key news
- Exhibit 160: Zoetis Inc. - Key offerings
- Exhibit 161: Zoetis Inc. - Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 162: Inclusions checklist
- Exhibit 163: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 164: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 165: Research methodology
- Exhibit 166: Validation techniques employed for market sizing
- Exhibit 167: Information sources
- 13.5 List of abbreviations
- Exhibit 168: List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
veterinary pain management market market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis